Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK expe...

por Sutherland, S, Ashley, S, Miles, D, Chan, S, Wardley, A, Davidson, N, Bhatti, R, Shehata, M, Nouras, H, Camburn, T, Johnston, S R D
Publicado 2010